glp-1 and celiac disease Disease, Semiglutide Gut Improvements : r/Semaglutide GLP-1 Agonists: Benefits, Side Effects
Description
Total weight loss by week 12 typically ranges from 5% to 8% of starting body weight, depending on the medication and dose
An important aspect of care when taking a medication that must be regularly injected subcutaneously is to rotate the injection sites
Dulaglutide was approved in the same year for T2DM but not for weight loss, and although it leads to modest weight reduction, this effect is significantly less than that achieved with semaglutide or liraglutide in obesity-focused trials [2326]
Lillys approval for Mounjaro in Obesity will result in a duopoly in the space, with clinical stage biopharma (mentioned below) likely 2 years from having a drug on the market
Acute kidney injury associated with semaglutide
Further prospective studies should be carried out to determine the potential effects of GLP-1 receptor agonists on thyroid disease
